Association between the Frailty and Cardiovascular Disease Risk in Populations with Cardiovascular-Kidney-Metabolic Syndrome Stages 0–3: A Prospective Cohort Study
American Journal of Nephrology · 2025
DOI: 10.1159/000548772 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift American Journal of Nephrology, 2025. Verfasst von Xunliang Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Frailty, Cardiovascular Diseases, Metabolic Syndrome, Cardio-Renal Syndrome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben.
Themen: Gerontologische Pflege
Abstract (Originalsprache)
Introduction
Previous studies found that frailty was an important risk factor for cardiovascular disease (CVD). However, the relationship between frailty and CVD risk across different cardiovascular-kidney-metabolic (CKM) syndrome stages remains poorly understood. This study investigated the association between frailty and incident CVD in populations with CKM syndrome stages 0–3.
Methods
We analyzed 6,049 middle-aged and older adults without pre-existing CVD data from the China Health and Retirement Longitudinal Study (2011–2020). Participants were categorized into CKM syndrome stages 0–3 based on the American Heart Association’s criteria. Frailty was assessed using the frailty index (FI) and classified as robust, pre-frail, or frail. Cox proportional hazard models examined the association between frailty and incident CVD.
Results
During a median follow-up of 7.5 years, 1,441 participants developed CVD. Compared to robust individuals, pre-frail and frail participants had multivariable-adjusted hazard ratios of 1.58 and 2.13 for incident CVD, respectively. Each standard deviation increase in FI was associated with a 28% higher risk of incident CVD. A dose-response relationship was observed between FI and CVD risk, with no significant nonlinearity was detected. These associations remained consistent across all CKM syndrome stages, although significant effect modifications were observed by age, gender, and hypertension status. Sensitivity analyses yielded consistent results.
Conclusions
Frailty is independently associated with increased CVD risk across the spectrum of CKM syndrome stages, with a clear dose-response relationship.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
- Institute of Kidney Disease, Inflammation and Immunity Mediated Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei, China.
- Furong Community Hospital, The Second Affiliated Hospital of Anhui Medical University, Hefei, China, 1303869606@qq.com.
- Department of Nephrology, The Second Affiliated Hospital of Anhui Medical University, Hefei, China, wangdeguang@ahmu.edu.cn.
- Institute of Kidney Disease, Inflammation and Immunity Mediated Diseases, The Second Affiliated Hospital of Anhui Medical University, Hefei, China, wangdeguang@ahmu.edu.cn.
Zitieren
APA
Li, X., Zhao, W., Zhao, L., Sun, T., Zhu, F., & Wang, D. (2025). Association between the Frailty and Cardiovascular Disease Risk in Populations with Cardiovascular-Kidney-Metabolic Syndrome Stages 0–3: A Prospective Cohort Study. American Journal of Nephrology. https://doi.org/10.1159/000548772
Vancouver
Li X, Zhao W, Zhao L, Sun T, Zhu F, Wang D. Association between the Frailty and Cardiovascular Disease Risk in Populations with Cardiovascular-Kidney-Metabolic Syndrome Stages 0–3: A Prospective Cohort Study. American Journal of Nephrology. 2025. doi:10.1159/000548772
BibTeX
@article{Li2025,
author = {Li, Xunliang and Zhao, Wenman and Zhao, Li and Sun, Tongxin and Zhu, Fuhai and Wang, Deguang},
title = {Association between the Frailty and Cardiovascular Disease Risk in Populations with Cardiovascular-Kidney-Metabolic Syndrome Stages 0–3: A Prospective Cohort Study},
journal = {American Journal of Nephrology},
year = {2025},
doi = {10.1159/000548772}
}
EUVIMED